Intentar ORO - Gratis
THE HIDDEN RISKS OF AMERICA'S MOST POPULAR PRESCRIPTION PAINKILLER
Mint Mumbai
|December 26, 2025
Gabapentin has soared in popularity as an alternative to opioids, but patients are finding it can cause harm
While the medical establishment has mostly maintained that gabapentin isn't habit-forming, some patients have reported debilitating adverse effects when they try to taper off it.
(istockphoto)
John Avery was just back from a guys’ golfing weekend and doing dead lifts at the gym in 2023 when he felt a pop in his lower back. A disc had slipped and was pressing on a nerve.
After months of rest, physical therapy and steroids, he was prescribed a drug called gabapentin by a pain management specialist who told Avery that it could help calm his nerve pain and that it was “nonaddictive,” Avery recalled. He took the medicine for a few days, then had surgery, and took it again for a little more than three weeks.
The 33-year-old former high-school physical education teacher in Newark, Ill., said he experienced a severe protracted withdrawal when he stopped, which led to neurological symptoms now that make his original back problem seem like “a paper cut” by comparison.
His symptoms include shaking and a burning sensation throughout his body, muscle spasms and a racing pulse. He can’t sleep for more than a half-hour at a time, and has lost so much weight that his wife said his calves are the size of her arms.
The change in his life, he said, is “beyond dramatic.”
Approved by the Food and Drug Administration decades ago for seizures and nerve pain from shingles, gabapentin is now the seventh-most widely prescribed drug in the U.S., according to the Iqvia Institute for Human Data Science. About 15.5 million people were prescribed gabapentin in 2024, according to an analysis by Centers for Disease Control and Prevention researchers.
Studies show that most of the prescriptions are written to treat conditions that it wasn't approved for—a practice that is legal and common, but means the FDA hasn't vetted its risks and benefits for those purposes.
Esta historia es de la edición December 26, 2025 de Mint Mumbai.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Mint Mumbai
Mint Mumbai
Airfares hit four-year low on weak traffic; IndiGo crisis dulls demand
India's average domestic airfares hit a four-year low in the December quarter, an unusual outcome for a seasonally strong period, as traffic slowed through 2025 and demand weakened on non-metro routes.
2 mins
January 10, 2026
Mint Mumbai
Jaipur's many sweet takes
A winter food walk through the bylanes of Pink City reveals rituals and craftsmanship
2 mins
January 10, 2026
Mint Mumbai
Better than the real thing
STREAM OF STORIES
3 mins
January 10, 2026
Mint Mumbai
XAI under fire for sexualized child photos on Grok
Elon Musk has repeatedly expanded the boundaries of permitted speech on his social-media platform X.
4 mins
January 10, 2026
Mint Mumbai
Federal Bank unveils Fortuna Wave to appeal to all young, mobile-first clients
Federal Bank's new brand identity, anchored by a refreshed logo called Fortuna Wave, comes at a moment when legacy banks are being forced to rethink how they appear, speak and scale—not because the old has failed, but because the audience has shifted.
3 mins
January 10, 2026
Mint Mumbai
Dec gold ETFs log record ₹11,647 cr
India’s equity investors are flocking to gold exchange- traded funds as a hedge against stock market volatility amid global headwinds.
1 min
January 10, 2026
Mint Mumbai
Blackstone checks into Taj Aravali, buys 50% for $110 mn
The asset manager eyes further expansion with significant stake in Bengaluru’s Ritz-Carlton
2 mins
January 10, 2026
Mint Mumbai
Jewellery in India isn't just about the flex
A new book, 'Silver & Gold', is a reminder that jewellery has links to faith and culture in India
3 mins
January 10, 2026
Mint Mumbai
US trade fears rattle markets; Nifty below 26,000
Domestic equities were shaken by the ‘Trump factor’ throughout the week, leaving India the worst-performing major market globally as risk-off sentiment gripped investors.
1 mins
January 10, 2026
Mint Mumbai
December inflation likely up at 1.6%: Poll
India’s retail inflation has likely inched up to 1.6% in December from 0.7% in November, driven by shallower deflation in food items and the fading impact of a favourable base effect, according to a Mint poll of 5 economists.
1 min
January 10, 2026
Listen
Translate
Change font size
